Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals-Reference-Cited by-同舟云学术

Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals

Published:2022-08-09 Issue:5 Volume:109 Page:441-446
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Elizabeth Smyth¹^ORCID,Aidan Kelly²,David O' Brien³,Deirdre Waldron³,Sarah Brophy²,Emer Atkinson⁴,Kanthi Perera⁵,Crotty Gerard M.⁵^ORCID,Aileen Walsh⁵,Michelle Connolly⁵,Ruth Clifford⁶,Hilary O'Leary⁶,Ashique Khan⁶,Bacon Christopher L.¹,Emily Smyth⁷,McElligott Anthony M.²^ORCID,Fiona Quinn⁴^ORCID,Elisabeth Vandenberghe¹^ORCID,Carmel Waldron¹^ORCID

Affiliation:

1. Department of Haematology Trinity St. James's Cancer Institute Dublin Ireland

2. John Durkan Leukaemia Laboratories Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute Dublin Ireland

3. Flow Cytometry Laboratory Trinity St. James's Cancer Institute Dublin Ireland

4. Cancer Molecular Diagnostics Laboratory Trinity St. James's Cancer Institute Dublin Ireland

5. Department of Haematology Midland's Regional Hospital Tullamore Ireland

6. Department of Haematology University Hospital Limerick Limerick Ireland

7. Department of Physiotherapy School of Medicine, Trinity College Dublin Dublin Ireland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13824

Reference30 articles.

1. Cancer Statistics, 2021

2. Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia

3. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

4. V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia